NO20084992L - Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel - Google Patents
Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddelInfo
- Publication number
- NO20084992L NO20084992L NO20084992A NO20084992A NO20084992L NO 20084992 L NO20084992 L NO 20084992L NO 20084992 A NO20084992 A NO 20084992A NO 20084992 A NO20084992 A NO 20084992A NO 20084992 L NO20084992 L NO 20084992L
- Authority
- NO
- Norway
- Prior art keywords
- nicotine
- trometamol
- disease
- oral formulation
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
En farmasøytisk oral formulering for levering av nikotin i en hvilken som helst form til et subjekt ved transmukosalt opptak i det orale hulrommet som innbefatter nikotin i en hvilken som helst form, hvori nevnte orale formulering er bufret med minst trometamol. Også omfattet er en fremgangsmåte for oral levering av nikotin i en hvilken som helst form, en fremgangsmåte for å redusere trangen til å røyke eller anvende tobakk så vel som fremgangsmåter for fremstilling av den orale formuleringen, anvendelse av den orale formuleringen for å oppnå transmukosalt opptak av nikotin i det orale hulrommet til et subjekt, og anvendelse av nikotin for fremstilling av en oral formulering for behandling av en sykdom valgt fra gruppen som består av tobakk- eller nikotinavhengighet, Alzheimers sykdom, Crohns sykdom, Parkinsons sykdom, Tourettes syndrom, ulcerøs kolitt og etter-røykingsopphør vektkontroll.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0601089 | 2006-05-16 | ||
PCT/SE2007/000364 WO2007133140A1 (en) | 2006-05-16 | 2007-04-18 | Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20084992L true NO20084992L (no) | 2009-02-13 |
NO342308B1 NO342308B1 (no) | 2018-05-07 |
Family
ID=38694148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084992A NO342308B1 (no) | 2006-05-16 | 2008-11-27 | Farmasøytisk produkt for intraoral avlevering av nikotin som innbefatter trometamol som buffer |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070269386A1 (no) |
EP (1) | EP2023958B2 (no) |
JP (1) | JP5710121B2 (no) |
KR (1) | KR20090033330A (no) |
CN (1) | CN101484188A (no) |
AR (1) | AR060932A1 (no) |
AU (1) | AU2007250588B2 (no) |
BR (1) | BRPI0711692A2 (no) |
CA (1) | CA2652499C (no) |
CY (1) | CY1119764T1 (no) |
DK (1) | DK2023958T4 (no) |
ES (1) | ES2649268T5 (no) |
HU (1) | HUE035266T2 (no) |
LT (1) | LT2023958T (no) |
MX (1) | MX2008014725A (no) |
NO (1) | NO342308B1 (no) |
NZ (1) | NZ572759A (no) |
PL (1) | PL2023958T5 (no) |
PT (1) | PT2023958T (no) |
RU (1) | RU2436566C2 (no) |
SI (1) | SI2023958T2 (no) |
TW (1) | TW200803916A (no) |
WO (1) | WO2007133140A1 (no) |
ZA (1) | ZA200810617B (no) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1648421T3 (en) * | 2003-07-24 | 2017-12-04 | Glaxosmithkline Llc | ORAL SOLUBLE MOVIES |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
AR071420A1 (es) | 2008-05-01 | 2010-06-16 | Smithkline Beecham Corp | Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla |
US20100055050A1 (en) * | 2008-08-30 | 2010-03-04 | Kathleen Moore | Nicotine chewing gum on a stick |
PL2198865T3 (pl) * | 2008-12-19 | 2012-04-30 | Siegfried Ltd | Produkt zawierający nikotynę |
US20100330058A1 (en) * | 2009-06-24 | 2010-12-30 | Hero Nutritionals, LLC | Chewable drug |
CN102770138B (zh) * | 2010-02-18 | 2015-12-09 | J·V·达卡 | 含有尼古丁的软凝胶锭剂 |
CN102869344A (zh) * | 2010-04-01 | 2013-01-09 | 帕玛内斯特公司 | 局部麻醉剂的生物黏附性组合物 |
EP2563344A1 (en) * | 2010-04-27 | 2013-03-06 | Novartis AG | Oral dosage forms |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US8529914B2 (en) * | 2010-06-28 | 2013-09-10 | Richard C. Fuisz | Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
DK201170369A (en) * | 2011-07-06 | 2013-01-07 | Fertin Pharma As | A nicotine-containing chewing gum piece packed in a wrapping of laminate |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9763928B2 (en) * | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9044035B2 (en) * | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
CN102633911B (zh) * | 2012-04-19 | 2013-12-25 | 陕西科技大学 | 淀粉微球负载氢氧化钙催化制备羟丙基-β-环糊精的方法 |
WO2013192413A1 (en) * | 2012-06-20 | 2013-12-27 | Mishra Munmaya K | Smokeless tobacco comprising lipid granules |
US9521864B2 (en) * | 2013-07-19 | 2016-12-20 | Altria Client Services Llc | Methods and systems for incorporating nicotine into oral products |
US9375033B2 (en) | 2014-02-14 | 2016-06-28 | R.J. Reynolds Tobacco Company | Tobacco-containing gel composition |
EP4360653A2 (en) * | 2015-03-26 | 2024-05-01 | Patheon Softgels Inc. | Liquisoft capsules |
GB201516729D0 (en) * | 2015-09-22 | 2015-11-04 | The Technology Partnership Plc | Liquid nicotine formulation |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
CN106880599B (zh) * | 2015-12-15 | 2021-07-06 | 永菳生科股份有限公司 | 含多单位载体的固态软式口溶锭 |
US20200085806A1 (en) * | 2016-12-20 | 2020-03-19 | Fertin Pharma A/S | A mucoadhesive oromucosal formulation comprising a nicotine complex |
JP7137850B2 (ja) | 2017-03-03 | 2022-09-15 | シーティーシー バイオ インク | バレニクリンまたはその薬学的に許容可能な塩の包接複合体を含む口腔投与用製剤 |
BR112020011238A2 (pt) * | 2017-12-08 | 2021-01-05 | Fertin Pharma A/S | Formulação de nicotina oral sólida para alívio de desejo de nicotina de início rápido, formulação de nicotina oral sólida para uso na atenuação do desejo de nicotina, método de atenuação do desejo de nicotina e bolsa oral |
PL3720418T3 (pl) * | 2017-12-08 | 2021-12-20 | Fertin Pharma A/S | Tabletka nikotynowa |
KR20200139170A (ko) * | 2018-04-06 | 2020-12-11 | 필립모리스 프로덕츠 에스.에이. | 니코틴 겔 |
BR112020025604A2 (pt) | 2018-06-15 | 2021-03-23 | R.J. Reynolds Tobacco Company | purificação de nicotina |
US11273123B2 (en) | 2018-07-18 | 2022-03-15 | USpharma Ltd | Chewable pharmaceutical dosage forms |
CN113260351A (zh) * | 2018-12-29 | 2021-08-13 | 3M创新有限公司 | 口腔制品及使用方法 |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11617744B2 (en) * | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
BR112022013163A2 (pt) * | 2020-01-15 | 2022-09-13 | Mcneil Ab | Produto e processo de fabricação de uma goma |
MX2022012002A (es) | 2020-03-27 | 2023-01-05 | Mcneil Ab | Cartucho con nicotina. |
CN112402418B (zh) * | 2020-12-16 | 2022-03-01 | 安徽中烟工业有限责任公司 | 一种单胺氧化酶b(mao-b)抑制剂及其应用 |
CN114680314B (zh) * | 2020-12-28 | 2024-03-15 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种用于红酒果酱的稳定剂、红酒果酱及其制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU411533B2 (en) † | 1965-03-24 | 1971-03-08 | The Colonial Sugar Refining Company Limited | Compositions of matter containing complex cariostatic agents |
US3877468A (en) * | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
US3901248A (en) * | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3845217A (en) * | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
US5783207A (en) * | 1985-05-01 | 1998-07-21 | University Of Utah Research Foundation | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
US5004651A (en) * | 1989-01-24 | 1991-04-02 | Abbott Laboratories | Stabilizing system for solid dosage forms |
US5824334A (en) * | 1989-09-05 | 1998-10-20 | University Of Utah Research Foundation | Tobacco substitute |
US5167242A (en) * | 1990-06-08 | 1992-12-01 | Kabi Pharmacia Aktiebolaq | Nicotine-impermeable container and method of fabricating the same |
SE9303574D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
US5889028A (en) * | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5810081A (en) * | 1997-02-24 | 1998-09-22 | Cobb; Delwin E. | Wear structure for bore hole separation device |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
FR2812642B1 (fr) * | 2000-08-03 | 2003-08-01 | Atofina | Procede de preparation d'un support de catalyseur pour la poymerisation de l'ethylene et des alpha-olefines, le support ainsi obtenu et le catalyseur correspondant |
SE0102197D0 (sv) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
SE0104388D0 (sv) * | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
US6579513B1 (en) * | 2002-01-03 | 2003-06-17 | Playtex Products, Inc. | Hygiene mouthspray composition |
US7767698B2 (en) * | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
US20040052851A1 (en) * | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
US20060002865A1 (en) † | 2004-06-30 | 2006-01-05 | Adonis Buelo | Stable baking soda/peroxide with calcium and phosphate whitening product |
-
2006
- 2006-06-01 US US11/444,787 patent/US20070269386A1/en not_active Abandoned
-
2007
- 2007-04-18 ES ES07748029T patent/ES2649268T5/es active Active
- 2007-04-18 NZ NZ572759A patent/NZ572759A/en unknown
- 2007-04-18 SI SI200731993T patent/SI2023958T2/sl unknown
- 2007-04-18 AU AU2007250588A patent/AU2007250588B2/en active Active
- 2007-04-18 PT PT77480291T patent/PT2023958T/pt unknown
- 2007-04-18 BR BRPI0711692-6A patent/BRPI0711692A2/pt not_active Application Discontinuation
- 2007-04-18 JP JP2009510916A patent/JP5710121B2/ja active Active
- 2007-04-18 WO PCT/SE2007/000364 patent/WO2007133140A1/en active Application Filing
- 2007-04-18 EP EP07748029.1A patent/EP2023958B2/en active Active
- 2007-04-18 LT LTEP07748029.1T patent/LT2023958T/lt unknown
- 2007-04-18 CN CNA2007800234638A patent/CN101484188A/zh active Pending
- 2007-04-18 RU RU2008149511/15A patent/RU2436566C2/ru active
- 2007-04-18 PL PL07748029T patent/PL2023958T5/pl unknown
- 2007-04-18 KR KR1020087030671A patent/KR20090033330A/ko not_active Application Discontinuation
- 2007-04-18 MX MX2008014725A patent/MX2008014725A/es active IP Right Grant
- 2007-04-18 CA CA2652499A patent/CA2652499C/en active Active
- 2007-04-18 HU HUE07748029A patent/HUE035266T2/en unknown
- 2007-04-18 DK DK07748029.1T patent/DK2023958T4/da active
- 2007-05-15 AR ARP070102086A patent/AR060932A1/es not_active Application Discontinuation
- 2007-05-15 TW TW096117124A patent/TW200803916A/zh unknown
-
2008
- 2008-11-27 NO NO20084992A patent/NO342308B1/no unknown
- 2008-12-15 ZA ZA2008/10617A patent/ZA200810617B/en unknown
-
2017
- 2017-12-19 CY CY20171101326T patent/CY1119764T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084992L (no) | Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel | |
MX2009012485A (es) | Formulacion oral de nicotina amortiguada con aminoacidos. | |
NO20084987L (no) | Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel | |
GB2465897A (en) | Respiratory disease treatment | |
WO2014093127A3 (en) | Method of administering nicotine, thc, tobacco, cannabidiol or base alkaloid and absorption conditioning unit | |
NO20071505L (no) | Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger. | |
WO2009141321A3 (en) | Tablettable chewing gums comprising nicotine and a buffering agent | |
WO2012001074A3 (en) | Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate | |
NO20084752L (no) | Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse | |
HK1097774A1 (en) | Stable pharmaceutical composition comprising linezolid from iv | |
IN2012DN03632A (no) | ||
MX2009012484A (es) | Formulacion de nicotina oral recubierta regulada con aminoacido. | |
NO20100301L (no) | Forbedrete brimonidinsammensetninger for behandling av erytem | |
MX2010003923A (es) | Formulacion farmaceutica de valsartan. | |
MX2010012999A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. | |
WO2009017837A3 (en) | Sublingual fentanyl spray | |
WO2006086107A3 (en) | Methods and compositions for minimizing accrual of inhalable insulin in the lungs | |
NZ620879A (en) | A novel formulation of indomethacin | |
MX2011005633A (es) | Formas de dosificacion solida de bendamustina. | |
WO2008069972A3 (en) | Systems for effecting cessation of tobacco use | |
NO20065453L (no) | Fenoksyalkykarboksylsyrederivater i behandlingen av inflammatoriske sykdommer. | |
WO2009117401A3 (en) | Compositions for site-specific delivery of imatinib and methods of use | |
RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
AR044599A1 (es) | Metodo para reducir los efectos perniciosos de la nicotina administrada por via oral o transdermica | |
WO2007124700A3 (en) | Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof |